rapid
spread
coronaviru
cov
caus
sever
acut
respiratori
syndrom
sar
led
report
probabl
case
china
alon
sinc
june
femal
patient
beij
ask
abort
follow
recoveri
infect
deadli
diseas
evid
indic
fetu
also
infect
patient
experienc
fever
april
seventh
month
pregnanc
patient
live
husband
visit
father
hospit
sever
time
diagnos
sar
march
husband
contract
fever
april
clinic
diagnos
probabl
sar
case
soon
afterward
pregnant
patient
experienc
fever
sinc
april
admit
ditan
hospit
diagnos
suspect
sar
case
april
abort
perform
may
specimen
matern
blood
umbil
blood
amniot
fluid
collect
surgeri
permiss
high
titer
immunoglobulin
g
igg
antibodi
sarscov
observ
matern
umbil
blood
sampl
antibodi
titer
evalu
seri
dilut
sar
igg
detect
kit
huada
biochem
compani
beij
china
indirect
immunofluoresc
assay
ifa
sarscov
enzymelink
immunosorb
assay
elisa
kit
licens
state
food
drug
administr
serolog
diagnosi
sar
kit
base
plate
coat
purifi
whole
viru
cultur
lysat
label
antihuman
igg
antibodi
indirect
elisa
detect
sarscov
antibodi
human
serum
plasma
mean
time
seroconvers
suggest
day
serumspecif
igg
cov
report
detect
clinic
diagnos
sar
patient
day
onset
diseas
procedur
perform
accord
manufactur
instruct
western
blot
purifi
protein
whole
sarscov
show
specif
igg
antibodi
nucleocapsid
n
protein
also
present
matern
blood
umbil
blood
amniot
fluid
fig
ifa
sarscov
also
posit
fig
kit
provid
euroimmun
medizinisch
labordiagnostika
ag
germani
slide
sar
virusinfect
cell
howev
sarscov
gene
detect
either
matern
blood
umbil
blood
fluid
use
sar
viru
fluoresc
quantit
pcr
diagnost
kit
da
gene
co
ltd
zhong
univers
guangzhou
china
specif
primer
fluorescencelabel
probe
design
within
gene
accord
sequenc
found
genbank
access
product
size
bp
run
includ
posit
sarscov
genom
templat
control
suppli
manufactur
construct
standard
curv
notempl
control
extract
detect
possibl
contamin
may
occur
process
sampl
data
analyz
softwar
provid
manufactur
human
cov
implic
respiratori
infect
hospit
neonat
cov
mous
hepat
viru
caus
infect
mild
adult
anim
often
gener
sever
sometim
lethal
diseas
neonat
matern
antibodi
suppli
via
placenta
colostrum
effici
protect
newborn
anim
fatal
consequ
acut
cov
infect
critic
phase
infect
gustafsson
et
al
transfer
matern
deriv
antibodi
enterotrop
mous
hepat
viru
pup
intrauterin
igg
lactogen
iga
igg
rout
observ
immun
mice
transmit
equal
level
antibodi
three
consecut
litter
pup
evid
declin
also
observ
chick
hatch
high
level
matern
antibodi
excel
protect
infecti
bronchiti
viru
challeng
day
age
sow
natur
infect
transmiss
gastroenter
viru
tgev
exhibit
pronounc
decreas
igg
antibodi
titer
tgev
transmiss
colostrum
milk
sow
prime
porcin
respiratori
cov
boost
tgev
provid
best
passiv
protect
tgev
challeng
exposur
litter
litter
mortal
also
morbid
reduc
observ
suggest
matern
antibodi
specif
sar
viru
detect
umbil
blood
amniot
fluid
potenti
protect
fetu
infect
sar
viru
rna
detect
umbilici
fluid
fecal
specimen
mouthwash
salin
pregnant
woman
examin
sar
viru
fluoresc
quantit
pcr
diagnost
kit
sampl
taken
hour
abort
surgeri
perform
indic
evid
transmiss
sar
viru
placent
barrier
although
vertic
transmiss
observ
mous
hepat
viru
chen
et
al
identifi
member
pregnancyspecif
glycoprotein
subgroup
carcinoembryon
antigen
gene
famili
serv
receptor
mous
hepat
viru
murin
cov
howev
unlik
pregnancyspecif
glycoprotein
express
placenta
express
predominantli
brain
unlik
pregnant
women
easili
infect
sarscov
nonpregn
women
